Pembrolizumab and lenalidomide induced remission in refractory double-hit lymphoma

MeSH terms

• Antibodies, Monoclonal, Humanized / administration & dosage
• Antineoplastic Combined Chemotherapy Protocols / administration & dosage
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
• Bendamustine Hydrochloride / administration & dosage
• Burkitt Lymphoma / drug therapy*
• Burkitt Lymphoma / pathology
• Cyclophosphamide / administration & dosage
• Doxorubicin / administration & dosage
• Drug Resistance, Neoplasm
• Humans
• Lenalidomide
• Lymphoma, Follicular / drug therapy*
• Lymphoma, Follicular / pathology
• Lymphoma, Large B-Cell, Diffuse / drug therapy*
• Lymphoma, Large B-Cell, Diffuse / pathology
• Male
• Middle Aged
• Neoplasms, Second Primary / drug therapy*
• Neoplasms, Second Primary / pathology
• Positron Emission Tomography Computed Tomography
• Prednisone / administration & dosage
• Remission Induction
• Rituximab / administration & dosage
• Salvage Therapy*
• Thalidomide / administration & dosage
• Thalidomide / analogs & derivatives
• Vincristine / administration & dosage